Quantitative intravoxel incoherent motion parameters derived from whole‐tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer

Many locally advanced rectal cancer (LARC) patients can benefit from neoadjuvant chemotherapy (NACT), with some achieving a pathological complete response (pCR). However, there is limited research reporting on the value of intravoxel incoherent motion (IVIM) in monitoring pCR in patients with LARC.

[1]  B. Choi,et al.  Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging-An Experimental Study in a Rabbit Model. , 2013, Radiology.

[2]  K. Haustermans,et al.  Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study , 2011, Annals of Surgical Oncology.

[3]  R. Steele,et al.  Objective assessment of morbidity and quality of life after surgery for low rectal cancer , 2002, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[4]  Steve Halligan,et al.  Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. , 2008, Radiology.

[5]  R. Grimm,et al.  Diffusion‐weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer , 2016, Journal of Magnetic Resonance Imaging.

[6]  S. Park,et al.  Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy , 2013, European Radiology.

[7]  Jun Sang Kim,et al.  Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01) , 2010, Annals of surgery.

[8]  D. Collins,et al.  Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases , 2013, European Radiology.

[9]  Jae Young Lee,et al.  Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer , 2011, European Radiology.

[10]  A. Kessels,et al.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery , 2001, The Lancet.

[11]  Y. Jeong,et al.  Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: Diffusion‐weighted 3 tesla MR imaging , 2012, Journal of magnetic resonance imaging : JMRI.

[12]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[13]  Bram Stieltjes,et al.  Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters—preliminary results , 2013, Neuroradiology.

[14]  J. Gama-Rodrigues,et al.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy , 2006, Journal of Gastrointestinal Surgery.

[15]  J. Gama-Rodrigues,et al.  Nonoperative approaches to rectal cancer: a critical evaluation. , 2011, Seminars in radiation oncology.

[16]  D. Le Bihan,et al.  Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future. , 2016, Radiology.

[17]  Y. Kapran,et al.  Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? , 2012, Diagnostic and interventional radiology.

[18]  J. Gama-Rodrigues,et al.  Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival , 2007, Journal of Gastrointestinal Surgery.

[19]  A. Tartaro,et al.  Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  D. Tait,et al.  Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy. , 2014, European journal of cancer.

[21]  P. Box.  Rectal cancer:assessment of complete response to preoperative combined radiation therapy with chemotherapy—conventional MR volumetry versus diffusion-weighted MR imaging , 2011 .

[22]  M. Gollub,et al.  Multiparametric MRI of Rectal Cancer in the Assessment of Response to Therapy: A Systematic Review , 2014, Diseases of the colon and rectum.

[23]  Y. Mazaheri,et al.  Diffusion-Weighted Magnetic Resonance Imaging of the Prostate: Improved Robustness With Stretched Exponential Modeling , 2012, Journal of computer assisted tomography.

[24]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[25]  Bram Stieltjes,et al.  An in vivo verification of the intravoxel incoherent motion effect in diffusion‐weighted imaging of the abdomen , 2010, Magnetic resonance in medicine.

[26]  C. V. D. van de Velde,et al.  A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD). , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  J. Gama-Rodrigues,et al.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. , 2014, International journal of radiation oncology, biology, physics.

[28]  S. Yeo,et al.  Definitive high-dose radiotherapy with concurrent chemotherapy for locally advanced rectal cancer , 2016, Medicine.

[29]  S. Fang,et al.  Watch and wait approach to rectal cancer: A review. , 2015, World journal of gastrointestinal surgery.

[30]  V. Cogliano.  International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.

[31]  Jong Seob Park,et al.  Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer , 2015, Medicine.

[32]  Yu Xiao-ping,et al.  Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma , 2016, Journal of magnetic resonance imaging : JMRI.

[33]  Geerard L Beets,et al.  Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Stoker,et al.  Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. , 2013, Radiology.

[35]  M. Gonen,et al.  Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  P. Lambin,et al.  Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  A. Erden,et al.  Mean ADC values discriminate rectal mucinous carcinomafrom rectal nonmucinous adenocarcinoma , 2017, Turkish journal of medical sciences.

[38]  Karin Haustermans,et al.  Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. , 2012, International journal of radiation oncology, biology, physics.

[39]  Xiaoyan Zhang,et al.  Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion‐weighted MRI in locally advanced rectal cancer: A prospective single‐center study , 2017, Journal of magnetic resonance imaging : JMRI.

[40]  Jae Young Lee,et al.  Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. , 2009, Radiology.

[41]  J. Cercueil,et al.  Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. , 2012, Radiology.

[42]  R. Newcombe,et al.  Rectal carcinoma: thin-section MR imaging for staging in 28 patients. , 1999, Radiology.

[43]  M. Hjermstad,et al.  Late side effects and quality of life after radiotherapy for rectal cancer. , 2010, International journal of radiation oncology, biology, physics.

[44]  H. Rhim,et al.  Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. , 2011, Radiology.

[45]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[46]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[47]  J. Hartley,et al.  Magnetic resonance imaging accuracy in assessing tumour down‐staging following chemoradiation in rectal cancer , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[48]  S. Andreola,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1998, International Journal of Colorectal Disease.

[49]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[50]  H. Vargas,et al.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. , 2016, Radiology.

[51]  B. Choi,et al.  Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. , 2014, Radiology.

[52]  B. Warren,et al.  Preoperative Chemoradiotherapy and Total Mesorectal Excision Surgery for Locally Advanced Rectal Cancer: Correlation With Rectal Cancer Regression Grade , 2004, Diseases of the colon and rectum.

[53]  R. Luepker,et al.  CEA – A Predictor for Pathologic Complete Response After Neoadjuvant Therapy for Rectal Cancer , 2013, Diseases of the colon and rectum.

[54]  C. Hanski.  Is mucinous carcinoma of the colorectum a distinct genetic entity? , 1995, British Journal of Cancer.

[55]  Weijun Peng,et al.  The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging , 2017, Oncotarget.